Price Chart

Profile

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products.  Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
URL https://www.lantheus.com
Investor Relations URL https://investor.lantheus.com
HQ State/Province Massachusetts
Sector Health Care
Industry Health Care Equipment & Supplies
Equity Style Small Cap/Growth
Next Earnings Release Nov. 06, 2024
Last Earnings Release Jul. 31, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products.  Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
URL https://www.lantheus.com
Investor Relations URL https://investor.lantheus.com
HQ State/Province Massachusetts
Sector Health Care
Industry Health Care Equipment & Supplies
Equity Style Small Cap/Growth
Next Earnings Release Nov. 06, 2024
Last Earnings Release Jul. 31, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A